 | • レポートコード：QFJ1-4797 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、組換えヒトEGFの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（≥98％SDS-PAGE、95％-98％SDS-PAGE、<95％SDS-PAGE）、用途別市場規模（科学研究、医薬品、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・組換えヒトEGFの市場動向 ・企業の競争状況、市場シェア ・組換えヒトEGFの種類別市場規模と予測2016-2027（≥98％SDS-PAGE、95％-98％SDS-PAGE、<95％SDS-PAGE） ・組換えヒトEGFの用途別市場規模と予測2016-2027（科学研究、医薬品、その他） ・組換えヒトEGFの北米市場規模2016-2027（アメリカ、カナダ） ・組換えヒトEGFの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換えヒトEGFのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換えヒトEGFの中南米市場規模2016-2027（メキシコ、ブラジル） ・組換えヒトEGFの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（FUJIFILM Irvine Scientific、PeproTech, Inc、R&D Systems (Bio-Techne)、Miltenyi Biotec、Thermo Fisher Scientific、Abcam PLC、BioLegend Way、STEMCELL Technologies、Eurofins DiscoverX、RayBiotech, Inc、Prospec-Tany、Tonbo Biosciences、EnQuire Bio、ScienCell Research Laboratories、BioVision, Inc、Abm Inc、Cell Guidance Systems、Creative BioMart、Sino Biological、Cell Sciences、Axol Bioscience） ・結論 |
Human EGF is a 6-kDa protein with 53 amino acid residues and three intramolecular disulfide bonds. EGF binds to the epidermal growth factor receptor. Initially, human EGF was known as urogastrone.
This report studies the Recombinant Human EGF (Epidermal Growth Factor) obtained by recombinant protein.
EGF acts by binding with high affinity to epidermal growth factor receptor (EGFR) on the cell surface.
This stimulates ligand-induced dimerization, activating the intrinsic protein-tyrosine kinase activity of the receptor.
The tyrosine kinase activity, in turn, initiates a signal transduction cascade that results in a variety of biochemical changes within the cell – a rise in intracellular calcium levels, increased glycolysis and protein synthesis, and increases in the expression of certain genes including the gene for EGFR – that ultimately lead to DNA synthesis and cell proliferation.
Market Analysis and Insights: Global Recombinant Human EGF Market
The global Recombinant Human EGF market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Human EGF market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Human EGF market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Human EGF market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Human EGF market.
Global Recombinant Human EGF Scope and Market Size
Recombinant Human EGF market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human EGF market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
≥98% SDS-PAGE
95%-98% SDS-PAGE
<95% SDS-PAGE
Segment by Application
Scientific Research
Medical Drug
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
FUJIFILM Irvine Scientific
PeproTech, Inc
R&D Systems (Bio-Techne)
Miltenyi Biotec
Thermo Fisher Scientific
Abcam PLC
BioLegend Way
STEMCELL Technologies
Eurofins DiscoverX
RayBiotech, Inc
Prospec-Tany
Tonbo Biosciences
EnQuire Bio
ScienCell Research Laboratories
BioVision, Inc
Abm Inc
Cell Guidance Systems
Creative BioMart
Sino Biological
Cell Sciences
Axol Bioscience
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human EGF Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ≥98% SDS-PAGE
1.2.3 95%-98% SDS-PAGE
1.2.4 <95% SDS-PAGE
1.3 Market by Application
1.3.1 Global Recombinant Human EGF Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Scientific Research
1.3.3 Medical Drug
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human EGF Market Perspective (2016-2027)
2.2 Recombinant Human EGF Growth Trends by Regions
2.2.1 Recombinant Human EGF Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant Human EGF Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Human EGF Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant Human EGF Industry Dynamic
2.3.1 Recombinant Human EGF Market Trends
2.3.2 Recombinant Human EGF Market Drivers
2.3.3 Recombinant Human EGF Market Challenges
2.3.4 Recombinant Human EGF Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human EGF Players by Revenue
3.1.1 Global Top Recombinant Human EGF Players by Revenue (2016-2021)
3.1.2 Global Recombinant Human EGF Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant Human EGF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant Human EGF Revenue
3.4 Global Recombinant Human EGF Market Concentration Ratio
3.4.1 Global Recombinant Human EGF Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human EGF Revenue in 2020
3.5 Recombinant Human EGF Key Players Head office and Area Served
3.6 Key Players Recombinant Human EGF Product Solution and Service
3.7 Date of Enter into Recombinant Human EGF Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human EGF Breakdown Data by Type
4.1 Global Recombinant Human EGF Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Human EGF Forecasted Market Size by Type (2022-2027)
5 Recombinant Human EGF Breakdown Data by Application
5.1 Global Recombinant Human EGF Historic Market Size by Application (2016-2021)
5.2 Global Recombinant Human EGF Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recombinant Human EGF Market Size (2016-2027)
6.2 North America Recombinant Human EGF Market Size by Type
6.2.1 North America Recombinant Human EGF Market Size by Type (2016-2021)
6.2.2 North America Recombinant Human EGF Market Size by Type (2022-2027)
6.2.3 North America Recombinant Human EGF Market Size by Type (2016-2027)
6.3 North America Recombinant Human EGF Market Size by Application
6.3.1 North America Recombinant Human EGF Market Size by Application (2016-2021)
6.3.2 North America Recombinant Human EGF Market Size by Application (2022-2027)
6.3.3 North America Recombinant Human EGF Market Size by Application (2016-2027)
6.4 North America Recombinant Human EGF Market Size by Country
6.4.1 North America Recombinant Human EGF Market Size by Country (2016-2021)
6.4.2 North America Recombinant Human EGF Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Human EGF Market Size (2016-2027)
7.2 Europe Recombinant Human EGF Market Size by Type
7.2.1 Europe Recombinant Human EGF Market Size by Type (2016-2021)
7.2.2 Europe Recombinant Human EGF Market Size by Type (2022-2027)
7.2.3 Europe Recombinant Human EGF Market Size by Type (2016-2027)
7.3 Europe Recombinant Human EGF Market Size by Application
7.3.1 Europe Recombinant Human EGF Market Size by Application (2016-2021)
7.3.2 Europe Recombinant Human EGF Market Size by Application (2022-2027)
7.3.3 Europe Recombinant Human EGF Market Size by Application (2016-2027)
7.4 Europe Recombinant Human EGF Market Size by Country
7.4.1 Europe Recombinant Human EGF Market Size by Country (2016-2021)
7.4.2 Europe Recombinant Human EGF Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human EGF Market Size (2016-2027)
8.2 Asia-Pacific Recombinant Human EGF Market Size by Type
8.2.1 Asia-Pacific Recombinant Human EGF Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant Human EGF Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant Human EGF Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant Human EGF Market Size by Application
8.3.1 Asia-Pacific Recombinant Human EGF Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant Human EGF Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant Human EGF Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant Human EGF Market Size by Region
8.4.1 Asia-Pacific Recombinant Human EGF Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant Human EGF Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Human EGF Market Size (2016-2027)
9.2 Latin America Recombinant Human EGF Market Size by Type
9.2.1 Latin America Recombinant Human EGF Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant Human EGF Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant Human EGF Market Size by Type (2016-2027)
9.3 Latin America Recombinant Human EGF Market Size by Application
9.3.1 Latin America Recombinant Human EGF Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant Human EGF Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant Human EGF Market Size by Application (2016-2027)
9.4 Latin America Recombinant Human EGF Market Size by Country
9.4.1 Latin America Recombinant Human EGF Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant Human EGF Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human EGF Market Size (2016-2027)
10.2 Middle East & Africa Recombinant Human EGF Market Size by Type
10.2.1 Middle East & Africa Recombinant Human EGF Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant Human EGF Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant Human EGF Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant Human EGF Market Size by Application
10.3.1 Middle East & Africa Recombinant Human EGF Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant Human EGF Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant Human EGF Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant Human EGF Market Size by Country
10.4.1 Middle East & Africa Recombinant Human EGF Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant Human EGF Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 FUJIFILM Irvine Scientific
11.1.1 FUJIFILM Irvine Scientific Company Details
11.1.2 FUJIFILM Irvine Scientific Business Overview
11.1.3 FUJIFILM Irvine Scientific Recombinant Human EGF Introduction
11.1.4 FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2016-2021)
11.1.5 FUJIFILM Irvine Scientific Recent Development
11.2 PeproTech, Inc
11.2.1 PeproTech, Inc Company Details
11.2.2 PeproTech, Inc Business Overview
11.2.3 PeproTech, Inc Recombinant Human EGF Introduction
11.2.4 PeproTech, Inc Revenue in Recombinant Human EGF Business (2016-2021)
11.2.5 PeproTech, Inc Recent Development
11.3 R&D Systems (Bio-Techne)
11.3.1 R&D Systems (Bio-Techne) Company Details
11.3.2 R&D Systems (Bio-Techne) Business Overview
11.3.3 R&D Systems (Bio-Techne) Recombinant Human EGF Introduction
11.3.4 R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2016-2021)
11.3.5 R&D Systems (Bio-Techne) Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Recombinant Human EGF Introduction
11.4.4 Miltenyi Biotec Revenue in Recombinant Human EGF Business (2016-2021)
11.4.5 Miltenyi Biotec Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Recombinant Human EGF Introduction
11.5.4 Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2016-2021)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Abcam PLC
11.6.1 Abcam PLC Company Details
11.6.2 Abcam PLC Business Overview
11.6.3 Abcam PLC Recombinant Human EGF Introduction
11.6.4 Abcam PLC Revenue in Recombinant Human EGF Business (2016-2021)
11.6.5 Abcam PLC Recent Development
11.7 BioLegend Way
11.7.1 BioLegend Way Company Details
11.7.2 BioLegend Way Business Overview
11.7.3 BioLegend Way Recombinant Human EGF Introduction
11.7.4 BioLegend Way Revenue in Recombinant Human EGF Business (2016-2021)
11.7.5 BioLegend Way Recent Development
11.8 STEMCELL Technologies
11.8.1 STEMCELL Technologies Company Details
11.8.2 STEMCELL Technologies Business Overview
11.8.3 STEMCELL Technologies Recombinant Human EGF Introduction
11.8.4 STEMCELL Technologies Revenue in Recombinant Human EGF Business (2016-2021)
11.8.5 STEMCELL Technologies Recent Development
11.9 Eurofins DiscoverX
11.9.1 Eurofins DiscoverX Company Details
11.9.2 Eurofins DiscoverX Business Overview
11.9.3 Eurofins DiscoverX Recombinant Human EGF Introduction
11.9.4 Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2016-2021)
11.9.5 Eurofins DiscoverX Recent Development
11.10 RayBiotech, Inc
11.10.1 RayBiotech, Inc Company Details
11.10.2 RayBiotech, Inc Business Overview
11.10.3 RayBiotech, Inc Recombinant Human EGF Introduction
11.10.4 RayBiotech, Inc Revenue in Recombinant Human EGF Business (2016-2021)
11.10.5 RayBiotech, Inc Recent Development
11.11 Prospec-Tany
11.11.1 Prospec-Tany Company Details
11.11.2 Prospec-Tany Business Overview
11.11.3 Prospec-Tany Recombinant Human EGF Introduction
11.11.4 Prospec-Tany Revenue in Recombinant Human EGF Business (2016-2021)
11.11.5 Prospec-Tany Recent Development
11.12 Tonbo Biosciences
11.12.1 Tonbo Biosciences Company Details
11.12.2 Tonbo Biosciences Business Overview
11.12.3 Tonbo Biosciences Recombinant Human EGF Introduction
11.12.4 Tonbo Biosciences Revenue in Recombinant Human EGF Business (2016-2021)
11.12.5 Tonbo Biosciences Recent Development
11.13 EnQuire Bio
11.13.1 EnQuire Bio Company Details
11.13.2 EnQuire Bio Business Overview
11.13.3 EnQuire Bio Recombinant Human EGF Introduction
11.13.4 EnQuire Bio Revenue in Recombinant Human EGF Business (2016-2021)
11.13.5 EnQuire Bio Recent Development
11.14 ScienCell Research Laboratories
11.14.1 ScienCell Research Laboratories Company Details
11.14.2 ScienCell Research Laboratories Business Overview
11.14.3 ScienCell Research Laboratories Recombinant Human EGF Introduction
11.14.4 ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2016-2021)
11.14.5 ScienCell Research Laboratories Recent Development
11.15 BioVision, Inc
11.15.1 BioVision, Inc Company Details
11.15.2 BioVision, Inc Business Overview
11.15.3 BioVision, Inc Recombinant Human EGF Introduction
11.15.4 BioVision, Inc Revenue in Recombinant Human EGF Business (2016-2021)
11.15.5 BioVision, Inc Recent Development
11.16 Abm Inc
11.16.1 Abm Inc Company Details
11.16.2 Abm Inc Business Overview
11.16.3 Abm Inc Recombinant Human EGF Introduction
11.16.4 Abm Inc Revenue in Recombinant Human EGF Business (2016-2021)
11.16.5 Abm Inc Recent Development
11.17 Cell Guidance Systems
11.17.1 Cell Guidance Systems Company Details
11.17.2 Cell Guidance Systems Business Overview
11.17.3 Cell Guidance Systems Recombinant Human EGF Introduction
11.17.4 Cell Guidance Systems Revenue in Recombinant Human EGF Business (2016-2021)
11.17.5 Cell Guidance Systems Recent Development
11.18 Creative BioMart
11.18.1 Creative BioMart Company Details
11.18.2 Creative BioMart Business Overview
11.18.3 Creative BioMart Recombinant Human EGF Introduction
11.18.4 Creative BioMart Revenue in Recombinant Human EGF Business (2016-2021)
11.18.5 Creative BioMart Recent Development
11.18 Sino Biological
.1 Sino Biological Company Details
.2 Sino Biological Business Overview
.3 Sino Biological Recombinant Human EGF Introduction
.4 Sino Biological Revenue in Recombinant Human EGF Business (2016-2021)
.5 Sino Biological Recent Development
11.20 Cell Sciences
11.20.1 Cell Sciences Company Details
11.20.2 Cell Sciences Business Overview
11.20.3 Cell Sciences Recombinant Human EGF Introduction
11.20.4 Cell Sciences Revenue in Recombinant Human EGF Business (2016-2021)
11.20.5 Cell Sciences Recent Development
11.21 Axol Bioscience
11.21.1 Axol Bioscience Company Details
11.21.2 Axol Bioscience Business Overview
11.21.3 Axol Bioscience Recombinant Human EGF Introduction
11.21.4 Axol Bioscience Revenue in Recombinant Human EGF Business (2016-2021)
11.21.5 Axol Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Recombinant Human EGF Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ≥98% SDS-PAGE
Table 3. Key Players of 95%-98% SDS-PAGE
Table 4. Key Players of <95% SDS-PAGE
Table 5. Global Recombinant Human EGF Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Recombinant Human EGF Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Recombinant Human EGF Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Recombinant Human EGF Market Share by Regions (2016-2021)
Table 9. Global Recombinant Human EGF Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Recombinant Human EGF Market Share by Regions (2022-2027)
Table 11. Recombinant Human EGF Market Trends
Table 12. Recombinant Human EGF Market Drivers
Table 13. Recombinant Human EGF Market Challenges
Table 14. Recombinant Human EGF Market Restraints
Table 15. Global Recombinant Human EGF Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Recombinant Human EGF Market Share by Players (2016-2021)
Table 17. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2020)
Table 18. Ranking of Global Top Recombinant Human EGF Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Recombinant Human EGF Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Recombinant Human EGF Product Solution and Service
Table 22. Date of Enter into Recombinant Human EGF Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Recombinant Human EGF Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Recombinant Human EGF Revenue Market Share by Type (2016-2021)
Table 26. Global Recombinant Human EGF Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Recombinant Human EGF Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Recombinant Human EGF Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Recombinant Human EGF Revenue Market Share by Application (2016-2021)
Table 30. Global Recombinant Human EGF Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Recombinant Human EGF Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Recombinant Human EGF Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Recombinant Human EGF Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Recombinant Human EGF Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Recombinant Human EGF Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Recombinant Human EGF Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Recombinant Human EGF Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Recombinant Human EGF Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Recombinant Human EGF Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Recombinant Human EGF Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Recombinant Human EGF Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Recombinant Human EGF Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Recombinant Human EGF Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Recombinant Human EGF Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Recombinant Human EGF Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Recombinant Human EGF Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Recombinant Human EGF Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Recombinant Human EGF Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Recombinant Human EGF Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Recombinant Human EGF Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Recombinant Human EGF Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Recombinant Human EGF Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Recombinant Human EGF Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Recombinant Human EGF Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Recombinant Human EGF Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Recombinant Human EGF Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Recombinant Human EGF Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Recombinant Human EGF Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Recombinant Human EGF Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Recombinant Human EGF Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Recombinant Human EGF Market Size by Country (2022-2027) & (US$ Million)
Table 62. FUJIFILM Irvine Scientific Company Details
Table 63. FUJIFILM Irvine Scientific Business Overview
Table 64. FUJIFILM Irvine Scientific Recombinant Human EGF Product
Table 65. FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 66. FUJIFILM Irvine Scientific Recent Development
Table 67. PeproTech, Inc Company Details
Table 68. PeproTech, Inc Business Overview
Table 69. PeproTech, Inc Recombinant Human EGF Product
Table 70. PeproTech, Inc Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 71. PeproTech, Inc Recent Development
Table 72. R&D Systems (Bio-Techne) Company Details
Table 73. R&D Systems (Bio-Techne) Business Overview
Table 74. R&D Systems (Bio-Techne) Recombinant Human EGF Product
Table 75. R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 76. R&D Systems (Bio-Techne) Recent Development
Table 77. Miltenyi Biotec Company Details
Table 78. Miltenyi Biotec Business Overview
Table 79. Miltenyi Biotec Recombinant Human EGF Product
Table 80. Miltenyi Biotec Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 81. Miltenyi Biotec Recent Development
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Recombinant Human EGF Product
Table 85. Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Abcam PLC Company Details
Table 88. Abcam PLC Business Overview
Table 89. Abcam PLC Recombinant Human EGF Product
Table 90. Abcam PLC Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 91. Abcam PLC Recent Development
Table 92. BioLegend Way Company Details
Table 93. BioLegend Way Business Overview
Table 94. BioLegend Way Recombinant Human EGF Product
Table 95. BioLegend Way Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 96. BioLegend Way Recent Development
Table 97. STEMCELL Technologies Company Details
Table 98. STEMCELL Technologies Business Overview
Table 99. STEMCELL Technologies Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 100. STEMCELL Technologies Recent Development
Table 101. Eurofins DiscoverX Company Details
Table 102. Eurofins DiscoverX Business Overview
Table 103. Eurofins DiscoverX Recombinant Human EGF Product
Table 104. Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 105. Eurofins DiscoverX Recent Development
Table 106. RayBiotech, Inc Company Details
Table 107. RayBiotech, Inc Business Overview
Table 108. RayBiotech, Inc Recombinant Human EGF Product
Table 109. RayBiotech, Inc Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 110. RayBiotech, Inc Recent Development
Table 111. Prospec-Tany Company Details
Table 112. Prospec-Tany Business Overview
Table 113. Prospec-Tany Recombinant Human EGF Product
Table 114. Prospec-Tany Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 115. Prospec-Tany Recent Development
Table 116. Tonbo Biosciences Company Details
Table 117. Tonbo Biosciences Business Overview
Table 118. Tonbo Biosciences Recombinant Human EGF Product
Table 119. Tonbo Biosciences Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 120. Tonbo Biosciences Recent Development
Table 121. EnQuire Bio Company Details
Table 122. EnQuire Bio Business Overview
Table 123. EnQuire Bio Recombinant Human EGF Product
Table 124. EnQuire Bio Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 125. EnQuire Bio Recent Development
Table 126. ScienCell Research Laboratories Company Details
Table 127. ScienCell Research Laboratories Business Overview
Table 128. ScienCell Research Laboratories Recombinant Human EGF Product
Table 129. ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 130. ScienCell Research Laboratories Recent Development
Table 131. BioVision, Inc Company Details
Table 132. BioVision, Inc Business Overview
Table 133. BioVision, Inc Recombinant Human EGF Product
Table 134. BioVision, Inc Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 135. BioVision, Inc Recent Development
Table 136. Abm Inc Company Details
Table 137. Abm Inc Business Overview
Table 138. Abm Inc Recombinant Human EGF Product
Table 139. Abm Inc Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 140. Abm Inc Recent Development
Table 141. Cell Guidance Systems Company Details
Table 142. Cell Guidance Systems Business Overview
Table 143. Cell Guidance Systems Recombinant Human EGF Product
Table 144. Cell Guidance Systems Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 145. Cell Guidance Systems Recent Development
Table 146. Creative BioMart Company Details
Table 147. Creative BioMart Business Overview
Table 148. Creative BioMart Recombinant Human EGF Product
Table 149. Creative BioMart Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 150. Creative BioMart Recent Development
Table 151. Sino Biological Company Details
Table 152. Sino Biological Business Overview
Table 153. Sino Biological Recombinant Human EGF Product
Table 154. Sino Biological Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 155. Sino Biological Recent Development
Table 156. Cell Sciences Company Details
Table 157. Cell Sciences Business Overview
Table 158. Cell Sciences Recombinant Human EGF Product
Table 159. Cell Sciences Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 160. Cell Sciences Recent Development
Table 161. Axol Bioscience Company Details
Table 162. Axol Bioscience Business Overview
Table 163. Axol Bioscience Recombinant Human EGF Product
Table 164. Axol Bioscience Revenue in Recombinant Human EGF Business (2016-2021) & (US$ Million)
Table 165. Axol Bioscience Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Human EGF Market Share by Type: 2020 VS 2027
Figure 2. ≥98% SDS-PAGE Features
Figure 3. 95%-98% SDS-PAGE Features
Figure 4. <95% SDS-PAGE Features
Figure 5. Global Recombinant Human EGF Market Share by Application: 2020 VS 2027
Figure 6. Scientific Research Case Studies
Figure 7. Medical Drug Case Studies
Figure 8. Others Case Studies
Figure 9. Recombinant Human EGF Report Years Considered
Figure 10. Global Recombinant Human EGF Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Recombinant Human EGF Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Recombinant Human EGF Market Share by Regions: 2020 VS 2027
Figure 13. Global Recombinant Human EGF Market Share by Regions (2022-2027)
Figure 14. Global Recombinant Human EGF Market Share by Players in 2020
Figure 15. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human EGF Revenue in 2020
Figure 17. Global Recombinant Human EGF Revenue Market Share by Type (2016-2021)
Figure 18. Global Recombinant Human EGF Revenue Market Share by Type (2022-2027)
Figure 19. North America Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Recombinant Human EGF Market Share by Type (2016-2027)
Figure 21. North America Recombinant Human EGF Market Share by Application (2016-2027)
Figure 22. North America Recombinant Human EGF Market Share by Country (2016-2027)
Figure 23. United States Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Recombinant Human EGF Market Share by Type (2016-2027)
Figure 27. Europe Recombinant Human EGF Market Share by Application (2016-2027)
Figure 28. Europe Recombinant Human EGF Market Share by Country (2016-2027)
Figure 29. Germany Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Recombinant Human EGF Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Recombinant Human EGF Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Recombinant Human EGF Market Share by Region (2016-2027)
Figure 39. China Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Recombinant Human EGF Market Share by Type (2016-2027)
Figure 47. Latin America Recombinant Human EGF Market Share by Application (2016-2027)
Figure 48. Latin America Recombinant Human EGF Market Share by Country (2016-2027)
Figure 49. Mexico Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Recombinant Human EGF Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Recombinant Human EGF Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Recombinant Human EGF Market Share by Country (2016-2027)
Figure 55. Turkey Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Recombinant Human EGF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 59. PeproTech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 60. R&D Systems (Bio-Techne) Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 61. Miltenyi Biotec Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 63. Abcam PLC Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 64. BioLegend Way Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 65. STEMCELL Technologies Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 66. Eurofins DiscoverX Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 67. RayBiotech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 68. Prospec-Tany Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 69. Tonbo Biosciences Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 70. EnQuire Bio Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 71. ScienCell Research Laboratories Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 72. BioVision, Inc Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 73. Abm Inc Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 74. Cell Guidance Systems Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 75. Creative BioMart Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 76. Sino Biological Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 77. Cell Sciences Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 78. Axol Bioscience Revenue Growth Rate in Recombinant Human EGF Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界のポリアクリルアミドゲル電気泳動（PAGE）市場規模・現状・予測（2021年-2027年） Polyacrylamide gel electrophoresis (PAGE) is a typical technique for protein separation by electrophoresis.In this technique, polyacrylamide gel is used as the base medium, while sodium dodecyl sulfate (SDS) is used for protein chain and protein denaturation. Market Analysis and Insights: Global Pol…- ポリアクリルアミドゲル電気泳動（PAGE）のグローバル市場：規模・現状・予測2019-2025 Polyacrylamide gel electrophoresis (PAGE) is a typical technique for protein separation by electrophoresis.In this technique, polyacrylamide gel is used as the base medium, while sodium dodecyl sulfate (SDS) is used for protein chain and protein denaturation.In 2018, the global Polyacrylamide Gel El…
- ポリアクリルアミドゲル電気泳動（PAGE）のグローバル市場：規模・現状・予測2019-2025 Polyacrylamide gel electrophoresis (PAGE) is a typical technique for protein separation by electrophoresis.In this technique, polyacrylamide gel is used as the base medium, while sodium dodecyl sulfate (SDS) is used for protein chain and protein denaturation.In 2018, the global Polyacrylamide Gel El…
- ランディングページビルダーのグローバル市場：規模・現状・予測2019-2025 Landing page builders enable non-technical users to deploy web pages designed to drive visitors to a specific conversion goal. In 2018, the global Landing Page Builders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …
- ランディングページビルダーのグローバル市場：規模・現状・予測2019-2025 Landing page builders enable non-technical users to deploy web pages designed to drive visitors to a specific conversion goal. In 2018, the global Landing Page Builders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …